NASHVILLE, TENN. (March 5, 2014) - FCA Venture Partners (“FCA”), a leading source of equity capital for early-stage companies in the Southeast and venture capital manager of Clayton Associates, announces the completion of its advisory board with the additions of Paul Rutledge, Herb Fritch, George Salem, Larry McTavish, and Leon Drennan. They join Larry Kloess, former President of HCA TriStar, Jim Fitzgerald, founder and former President of Health Trust Purchasing Group, John Ingram, CEO of Ingram Content Group, Aubrey Harwell, managing partner of Neal & Harwell, PLC, Stuart McWhorter, Partner and Chairman of Clayton Associates, and Clayton McWhorter, Founder and Chairman Emeritus of Clayton Associates.
Read MoreJumpstart Foundry has raised a round of venture capital from a diverse group of investors and with Clayton Associates leading the round. This capital will support both the annual accelerator and the new corporate innovation joint venture with the Nashville Entrepreneur Center – Jumpwerx. “It is an exciting step that capitalizes the firm and positions us to reach our full potential as Nashville’s engine for corporate innovation and successful start-ups,” said Vic Gatto, CEO and Founder of JSF.
Read MoreAt ComicBook.com, a Brentwood-based site dedicated to comic book industry news and related pop culture, Terry will oversee the company’s corporate strategy and day-to-day management. He will remain CEO of 247Sports, which is also based in Brentwood.
Read MoreFCA Venture Partners, the venture capital manager of investment firm Clayton Associates, announced today that Andrew Bouldin has been promoted to Principal.
Andrew joined FCA in 2010 as an associate. His work is primarily focused on FCA’s most recent fund, FCA V, a $53M fund investing in the healthcare services and information technologies industries, targeting early to growth stage businesses led by strong management teams with capital efficient, scalable, and disruptive business models.
Read MoreNashville-based NuScriptRX has named a new chief executive officer.
C. Daniel Haron, formerly president of Cigna Pharmacy Management, is the mail-orderinstitutional pharmacy’s new CEO, according toa news release. Haron replaces board memberDonald Taylor, who has served as interim CEO since July 2012.
Last November, Clayton Associates hosted a CEO Forum with the management teams of all of its healthcare related portfolio companies.
The featured guest were Bill Carpenter, CEO of LifePoint Hospitals, and Bill Rutherford, CFO of Hospital Corporation of America.
Read MoreGemino Healthcare Finance ("Gemino") today announced it has been acquired by Solar Senior Capital Ltd. (SUNS) ("Solar Senior Capital"). Over the last seven years, Philadelphia-based Gemino has earned a strong reputation in the market as a provider of asset-based and term financing solutions for small to mid-size healthcare companies.
Read MoreClinical Ink, the pioneering provider of eSource solutions for clinical trials, has announced a $4.3M Series B Investment Round led by FCA Venture Partners. “This infusion of funds will allow Clinical Ink to aggressively build the capabilities needed to address the rapidly increasing customer demand for eSource technology in clinical trials,” said Ed Seguine, CEO of Clinical Ink. “Our business has more than doubled in the last year and we will be expanding our management team, development capabilities, and implementation resources to support a wider range of clinical trials globally. Our customers, from large pharma to small biotech, have achieved real productivity gains at a fraction of the cost of current solutions and we will be in a position to continue to support innovative approaches to remote monitoring, site selection, and data management.”
Read More